Dracen

Developer of thaerapeutics for the treatment of cancers

placeBaltimore, Maryland, United States calendar_todayFounded 2017 groups8 employees language dracenpharma.com

Registered entities

Investor mix

4 investors on record; lead investors include Deerfield, i&i Bio.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Bank & private debt125%
Coming soon